TI
LEGN icon

Trexquant Investment’s Legend Biotech LEGN Stock Holding History

Trexquant Investment’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-191,993
Closed -$3.47M – 2081
2026
Q1 		$3.47M Buy
+191,993
New +$3.66M 0.03% 797
2025
Q2 		– Sell
-110,840
Closed -$3.76M – 1729
2025
Q1 		$3.76M Buy
+110,840
New +$3.98M 0.04% 618
2024
Q4 		– Sell
-76,549
Closed -$3.73M – 1725
2024
Q3 		$3.73M Buy
76,549
+23,209
+44% +$1.24M 0.05% 584
2024
Q2 		$2.36M Buy
+53,340
New +$2.46M 0.04% 681
2024
Q1 		– Sell
-25,949
Closed -$1.56M – 1630
2023
Q4 		$1.56M Buy
+25,949
New +$1.64M 0.04% 651
2022
Q4 		– Sell
-47,605
Closed -$1.94M – 1570
2022
Q3 		$1.94M Buy
+47,605
New +$2.23M 0.07% 369
2022
Q2 		– Sell
-8,366
Closed -$304K – 1701
2022
Q1 		$304K Buy
8,366
+2,198
+36% +$86.8K 0.01% 994
2021
Q4 		$287K Sell
6,168
-8,212
-57% -$417K 0.02% 943
2021
Q3 		$727K Buy
14,380
+4,182
+41% +$174K 0.06% 408
2021
Q2 		$419K Buy
+10,198
New +$347K 0.04% 570

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Trexquant Investment's LEGN Position: Q2 2026 in Review

Trexquant Investment sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 191,993 shares — an estimated $3.47M sold.

Trexquant Investment first reported a position in LEGN in Q2 2021 and held it in 10 quarters. The position peaked at $3.76M in Q1 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Trexquant Investment reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 191,993 Legend Biotech shares in Q2 2026, an estimated $3.47M.
  • Trexquant Investment first reported a position in Legend Biotech in Q2 2021 and held it in 10 quarters.
  • Trexquant Investment's Legend Biotech position peaked at $3.76M in Q1 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.